If the clinical trial is successful, Pfizer could submit a license for authorization to the FDA in 2025. The vaccine will not be available to the general public until then. Although the vaccine is still a few years away from potentially being available to the public, Dr. Dalal still believes it could be a “game-changer” in the fight against Lyme disease. Other prevention methods can help against Lyme disease, but a vaccine would be significant, he says. “Hopefully once approved, we will be able to contain this pesky bacterial infection which comes in the spring, summer, and also now into fall and sometimes even into early winter,” Dr. Dalal says.